Restart Life Sciences(NMLSF)
$0.06+0.05 (+320.00%)
NMLSF
Restart Life Sciences financials statements
$0.06
At close:+0.05 (+320.00%)
Restart Life Sciences (NMLSF) Income Statement
31 Followers
Restart Life Sciences Income Statement
Last quarter (Q2 2026), Restart Life Sciences's total revenue was C$331.16K. In Q2, Restart Life Sciences's net income was C$-1.02M. See Restart Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ 0.00 | C$ 0.00 | C$ 25.41K | C$ -3.79K | C$ -5.00K | |
| C$ 1.35M | C$ 658.51K | C$ 1.26M | C$ 1.94M | C$ 2.93M | |
| Depreciation and Amortization | C$ 1.85K | C$ 2.31K | C$ 2.94K | C$ 3.79K | C$ 5.00K |
| C$ -1.34M | C$ -656.20K | C$ -1.20M | C$ -1.84M | C$ -2.68M | |
| C$ -1.35M | C$ -658.51K | C$ -1.23M | C$ -1.94M | C$ -2.93M | |
| C$ -45.22K | C$ 883.26K | C$ 7.74K | C$ -527.00K | C$ 249.46K | |
| C$ -1.39M | C$ 224.75K | C$ -1.22M | C$ -2.47M | C$ -2.68M | |
| C$ -1.39M | C$ 224.75K | C$ -1.22M | C$ -3.76M | C$ -2.68M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.04 | C$ 0.01 | C$ -0.01 | C$ -0.02 | C$ -0.02 |
| Diluted EPS | C$ -0.04 | C$ 0.01 | C$ -0.01 | C$ -0.02 | C$ -0.02 |
| Weighted Average Shares Outstanding | 33.90M | 15.29M | 146.76M | 136.56M | 111.10M |
| Weighted Average Shares Outstanding (Diluted) | 33.90M | 16.11M | 146.76M | 136.56M | 111.10M |
Currency in CAD
